AstraZeneca Share Price (AZN)

4,650.50 +41.50 (+0.90%) delayed: 9:06AM GMT
Bid price 4,650.00 Open price 4,633.50
Ask price 4,651.00 Prev close 4,609.00
High price 4,685.46 Spread 0.02%
Low price 4,611.00 Volume 325,714

Register now for FREE live AstraZeneca share prices, AstraZeneca stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get AstraZeneca Level 2 Data, indepth research tools and investor commentary for AstraZeneca (AZN) and other London Stock Exchange equities.

AstraZeneca Share Price Chart

Advanced Charts >>

Register now for FREE AstraZeneca share price charts

AstraZeneca Share Price Information

Name AstraZeneca Epic AZN
Sector Pharmaceuticals & Biotechnology ISIN GB0009895292
Activites One of the world's leading pharmaceutical companies. Index FTSE 100

AstraZeneca Key Numbers

Latest Share Price (p) 4,650.50 Net Gearing (%) 65.32
Market Capitalisation (£m) 58,209.13 Gross Gearing (%) 73.34
Shares in issue (m) 1,265.28 Debt Ratio 64.74
P/E Ratio 16.61 Debt-to-Equity Ratio 0.67
Total dividends per share (p) 218.90 Assets / Equity Ratio 3.75
Dividend Yield (%) 4.76 Price to book value 3.49
Dividend cover (x) 2.79 ROCE (%) 7.51
Earning per share (p) 277.00 EPS Growth (%) 24.22
52 week high / low 5,505.00 / 3,680.00 DPS Growth (%) 16.13

AstraZeneca Director Deals

Dec.Date Type Director Pos No. of Shares
16/12/2016 TOUT Pascal Soriot CEO 59,951
01/11/2016 BUY Graham Chipchase NED 100
01/08/2016 TIN Marc Dunoyer FD 43,730
14/06/2016 TIN Pascal Soriot CEO 84,316
26/02/2016 TIN Pascal Soriot CEO 3,039

More AstraZeneca Director Deals >>

AstraZeneca Company News

13:56 24/02/2017

AZN's ZS-9 receives positive feedback

AstraZeneca (AZN) has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of ZS-9 (sodium zirconium cyclosilicate) for the treatment of hyperkalaemia. The recommendation is based...

12:32 24/02/2017

CHMP positive opinion for ZS-9 in hyperkalaemia

RNS Number : 8210X AstraZeneca PLC 24 February 2017   This announcement contains inside information   24 February 2017 12:30 GMT   ZS-9 (sodium zirconium cyclosilicate) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF HYPERKALAEMIA   AstraZeneca...

09:00 22/02/2017

Broker Forecast - Berenberg issues a broker note on AstraZeneca PLC

Berenberg today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 5450p (from 5500p). Story provided by StockMarketWire.com

More AstraZeneca Company News >>

Register now for FREE AstraZeneca company news

AstraZeneca Share Price Discussions

6 months ago

Any views on Astrazeneca (AZN)

Got a good line of products, but the share price seem to go down , could it be due to the weak us dollar.

more than 1 year ago

Two Peaches!!!! (AZN)

(option stock price + price paid) (stock option sell price chnge on day for option) LOG MAY 280 PUT 23+6 263 24 AZN MAY 2600 PUT 104+25 2548 118 THESE WILL MOVE QUICKLY!

more than 1 year ago

FTSE signals (AZN)

FTSE 100 :4410.7+25 @16:36 MAIN S/R 4518 TARGET 4375/1 MINI S/R 4446 TARGET 4357/1 VOL 2850 YIELD 3.26 BAROMETER 32 LONG FTSE FUTURE (JUN 04) ARE @ 4423, 13 POINTS ABOVE CASH AND 1.5 ABOVE FAIR VALUE OF +11.5 DOW @ 10396+39 @ 17:00 (PUT YOUR SHORTS ON!!)

Register now for FREE AstraZeneca share price discussions